October 31, 2013
"Antibodies derived from the blood of HIV-infected people suppressed the virus in the blood of monkeys in two studies that suggest the experimental approach may improve AIDS therapy or point the way toward a cure," Bloomberg reports (Bennett, 10/30). "The two studies, published on Wednesday in the journal Nature, involve the use of rare antibodies made by 10 percent to 20 percent of people with HIV that can neutralize a wide array of strains," Reuters notes (Steenhuysen, 10/30). "Two groups, from Harvard Medical School and the National Institute of Allergy and Infectious Diseases, performed the first trials of these antibodies," BBC News reports (Gallagher, 10/30). "The study results 'could revolutionize efforts to cure HIV' if the approach is found to work in people, said a commentary published Wednesday by the journal Nature along with the monkey studies," the Associated Press writes (Ritter, 10/30). According to Nature, "both teams plan to move their research into human trials" (Ledford, 10/30).
This information was reprinted from kff.org with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives, and sign up for email delivery. © Henry J. Kaiser Family Foundation. All rights reserved.